| Ryan Russell Zettle, PHARMD | |
|
167 N Main St, Tuba City, AZ 86045 | |
| (928) 283-2754 | |
| Not Available |
| Full Name | Ryan Russell Zettle |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 167 N Main St, Tuba City, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114215092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 03331104 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Russell Zettle, PHARMD 167 N Main St, Tuba City, AZ 86045 Ph: (928) 283-2754 | Ryan Russell Zettle, PHARMD 167 N Main St, Tuba City, AZ 86045 Ph: (928) 283-2754 |
News Archive
According to the Australian Nurses Federation (ANF) there are more than 18,000 reports of accidental needle stick injuries to nurses caused by syringes or other sharp items in Australia each year. This increases their risk of contracting deadly blood borne diseases like HIV/AIDS, hepatitis B and C etc. The authorities believe that these figures although alarming are not reflective of the true figures with many nurses choosing to keep their exposure under wraps.
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center - led New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.
Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences.
› Verified 1 days ago
Mursal A Mursal, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Tuba City, AZ 86045 Phone: 928-283-1432 | |
Rachel M Bartlett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main Street, Tuba City, AZ 86045 Phone: 928-283-2754 | |
Dr. David Frank Foss, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 North Main Street, Tuba City Regional Health Care Corporation, Tuba City, AZ 86045 Phone: 928-283-2755 Fax: 928-283-2758 | |
Sarah Sohn, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St., Tuba City, AZ 86045 Phone: 866-976-5941 | |
Daniel Robert Gilberg, PHARMD, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 North Main Street, Tuba City, AZ 86045 Phone: 928-283-2501 Fax: 928-283-2677 | |
Jessica T Lyerly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 N Main St, Tuba City, AZ 86045 Phone: 928-283-1342 Fax: 928-283-2758 | |
Courtney Wong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Tuba City, AZ 86045 Phone: 866-976-5941 |